Legal & General Group
ADAG

Legal & General Group’s Adagene ADAG Stock Holding History

Legal & General Group’s Portfolio ADAG Stock Details ADAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,000
Closed -$54K – 3478
2021
Q1 		$54K Buy
+3,000
New +$68.3K ﹤0.01% 2792

Other funds holding ADAG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
SVI
Strategic Vision Investment Hong Kong $157M AUM 125.87% 1-Year Est. Return

Legal & General Group's ADAG Position: Q2 2021 in Review

Legal & General Group sold out of Adagene (ADAG) in Q2 2021, closing a stake of 3,000 shares — an estimated $54K sold.

Legal & General Group first reported a position in ADAG in Q1 2021 and held it in 1 quarter. The position peaked at $54K in Q1 2021. 16 funds tracked by Wall St. Rank hold ADAG as of Q2 2021.

  • Legal & General Group reported no remaining Adagene position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 3,000 Adagene shares in Q2 2021, an estimated $54K.
  • Legal & General Group first reported a position in Adagene in Q1 2021 and held it in 1 quarter.
  • Legal & General Group's Adagene position peaked at $54K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Adagene as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.